Dr. Ross is a nationally recognized physician executive who lends deep industry knowledge to his senior search assignments, which focus on securing top executives for Academic Health Science Centers. He led the successful financial and academic turnaround of the Drexel School of Medicine (formerly MCP Hahnemann).

Previously, Dr. Ross served as executive associate dean at the University of Florida’s College of Medicine, and then as chief executive officer of the University of Florida Health System. In this role, he led the strategic direction of the academic medical center’s clinical enterprise, including mergers and acquisitions, network development, and managed care strategy.

Dr. Ross attended the University of Florida for undergraduate and medical studies and completed a residency in internal medicine at UNC-Chapel Hill and a medical oncology fellowship at the National Cancer Institute. As a faculty member, he received peer-reviewed funding continuously for 12 years to lead a National Cooperative Drug Discovery Group that was responsible for the identification of a novel class of cancer chemotherapy agents now commonly used. He was also elected “Teacher of the Year” four times, and also received the prestigious Hippocratic Award from the University of Florida College of Medicine for best exemplifying the qualities of a physician.

Dr. Ross is board certified in internal medicine and medical oncology, and is a member of the American Society of Clinical Oncology. He has served in advisory roles to the American Association of Medical Colleges, the Liaison Committee for Medical Education and the Institute of Medicine. He recently completed a three-year term on the board of directors of Tampa General Hospital.